Stock Insider Trading (from SEC Form 4)

NVTR / Nuvectra Corporation insiders include Zelibor Thomas Edward, Fahey Kathy Jo (VP of Regulatory & Clinical), Bihl Anthony P III, Hickman Thomas Kelley (EVP, Sales & Marketing), DREES SCOTT F (CEO), GREATBATCH, INC., Kaula Norbert (EVP, Research & Development), HAWARI KENNETH G JOHNSON DAVID D, and BERGER WALTER Z (CFO), MILLER JOSEPH A, PARKS FRED B, Hanchin Joseph Paul (President), Tremmel Jon T, .

Nuvectra Corporation insider trades are found here. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

Job titles are listed as of the filing and may not be current. Click the link icon to see the full transaction history.

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.
Latest
File Date
Latest
Tran Date
Insider Code Shares Post Shares Percent
Change
Share
Price
Tran Value Post Value Percent
Change
2018-01-10 2018-01-10 Zelibor Thomas Edward Director
M 837 5,863 16.65 9.79 8,194
2018-01-10 2017-01-10 Tremmel Jon T Director
M 837 5,863 16.65 9.79 8,194
2018-01-10 2018-01-10 PARKS FRED B Director
M 837 5,863 16.65 9.79 8,194
2018-01-10 2018-01-10 MILLER JOSEPH A Director
M 837 43,758 1.95 9.79 8,194
2018-01-10 2018-01-10 JOHNSON DAVID D Director
M 837 35,863 2.39 9.79 8,194
2018-01-10 2018-01-10 HAWARI KENNETH G Director
M 837 22,863 3.80 9.79 8,194
2018-01-10 2018-01-10 Bihl Anthony P III Director
M 837 9,302 9.89 9.79 8,194
2018-01-09 2018-01-07 Kaula Norbert EVP, Research & Development
M 499 3,769 15.26 7.86 3,922
2018-01-09 2018-01-07 Hanchin Joseph Paul President
M 4,273 29,933 16.65 7.86 33,586
2018-01-09 2018-01-07 DREES SCOTT F CEO, Director
M 16,024 157,248 11.35 7.86 125,949
2018-01-09 2018-01-07 BERGER WALTER Z CFO
M 8,012 56,124 16.65 7.86 62,974
2017-07-25 2017-07-25 Hickman Thomas Kelley EVP, Sales & Marketing
M 499 3,442 16.96 11.92 5,948
2017-04-11 2017-04-07 Fahey Kathy Jo VP of Regulatory & Clinical
M 1,247 2,854 77.60 6.36 7,931
2016-03-15 2016-03-14 GREATBATCH, INC. 10% Owner
J -10,258,278 0 -100.00
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)

Related News Stories

Nuvectra's (NVTR) CEO Scott Drees on Q3 2017 Results - Earnings Call Transcript

2017-11-01 seekingalpha
Good day, ladies and gentlemen. And welcome to the Q3 2017 Nuvectra Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. [Operator Instructions] (1-0)

BRIEF-Nuvectra corp files for mixed shelf of upto $100 mln

2017-10-05 reuters
* Nuvectra Corp files for mixed shelf of upto $100 million - sec filing‍​ Source text : bit.ly/2hQeDbP Further company coverage: (1-0)